Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis

Theodora Bejan-Angoulvant 1 David Ternant 1 Fadela Daoued Frédéric Medina Louis Bernard 2 Saloua Mammou Gilles Paintaud 1 Denis Mulleman 1
1 GICC UMR 7292 CNRS - Génétique, immunothérapie, chimie et cancer (GICC), UMR 7292 CNRS [2012-2017]
2 Service des Maladies Infectieuses
Abstract : Tumor necrosis factor inhibitors are effective in reducing inflammation in rheumatic diseases but increase the risk of infections. This study was undertaken to investigate the relationship between the trough serum concentration of infliximab (IFX) and the risk of a first infection episode.
Document type :
Journal articles
Complete list of metadatas
https://hal-univ-tours.archives-ouvertes.fr/hal-01980809
Contributor : Denis Mulleman <>
Submitted on : Monday, January 14, 2019 - 4:39:31 PM
Last modification on : Wednesday, December 4, 2019 - 2:38:03 PM

Identifiers

Collections

UNIV-TOURS | CNRS

Citation

Theodora Bejan-Angoulvant, David Ternant, Fadela Daoued, Frédéric Medina, Louis Bernard, et al.. Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis. Arthritis & rheumatology, Wiley, 2017, 69 (1), pp.108-113. ⟨10.1002/art.39841⟩. ⟨hal-01980809⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

56

Contact

CCSD